ICON Return on Tangible Equity 2010-2025 | ICLR
Current and historical return on tangible equity values for ICON (ICLR) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| ICON Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-06-30 | $0.79B | $-2.98B | -26.35% |
| 2025-03-31 | $0.76B | $-3.07B | -24.99% |
| 2024-12-31 | $0.79B | $-3.09B | -25.51% |
| 2024-09-30 | $0.75B | $-2.92B | -23.07% |
| 2024-06-30 | $0.71B | $-3.06B | -20.41% |
| 2024-03-31 | $0.68B | $-3.34B | -18.00% |
| 2023-12-31 | $0.61B | $-3.64B | -15.01% |
| 2023-09-30 | $0.51B | $-3.96B | -11.78% |
| 2023-06-30 | $0.51B | $-4.25B | -10.98% |
| 2023-03-31 | $0.51B | $-4.49B | -10.37% |
| 2022-12-31 | $0.51B | $-4.75B | -9.74% |
| 2022-09-30 | $0.46B | $-5.10B | -8.57% |
| 2022-06-30 | $0.21B | $-5.33B | -3.76% |
| 2022-03-31 | $0.17B | $-5.55B | -4.21% |
| 2021-12-31 | $0.15B | $-5.68B | -6.46% |
| 2021-09-30 | $0.18B | $-5.78B | -24.13% |
| 2021-06-30 | $0.36B | $1.04B | 40.92% |
| 2021-03-31 | $0.34B | $0.95B | 43.26% |
| 2020-12-31 | $0.33B | $0.85B | 48.95% |
| 2020-09-30 | $0.33B | $0.73B | 51.32% |
| 2020-06-30 | $0.33B | $0.60B | 54.60% |
| 2020-03-31 | $0.38B | $0.54B | 61.89% |
| 2019-12-31 | $0.37B | $0.71B | 60.37% |
| 2019-09-30 | $0.36B | $0.59B | 62.72% |
| 2019-06-30 | $0.35B | $0.60B | 63.04% |
| 2019-03-31 | $0.33B | $0.58B | 64.69% |
| 2018-12-31 | $0.32B | $0.54B | 70.10% |
| 2018-09-30 | $0.31B | $0.52B | 74.23% |
| 2018-06-30 | $0.30B | $0.42B | 83.16% |
| 2018-03-31 | $0.29B | $0.36B | 84.96% |
| 2017-12-31 | $0.28B | $0.35B | 88.57% |
| 2017-09-30 | $0.28B | $0.29B | 95.38% |
| 2017-06-30 | $0.27B | $0.36B | 91.03% |
| 2017-03-31 | $0.27B | $0.27B | 97.30% |
| 2016-12-31 | $0.26B | $0.27B | 102.34% |
| 2016-09-30 | $0.25B | $0.30B | 117.07% |
| 2016-06-30 | $0.25B | $0.26B | 123.76% |
| 2016-03-31 | $0.25B | $0.19B | 104.64% |
| 2015-12-31 | $0.24B | $0.11B | 84.34% |
| 2015-09-30 | $0.23B | $0.25B | 62.81% |
| 2015-06-30 | $0.22B | $0.40B | 51.23% |
| 2015-03-31 | $0.20B | $0.38B | 45.40% |
| 2014-12-31 | $0.18B | $0.44B | 36.90% |
| 2014-09-30 | $0.16B | $0.49B | 31.27% |
| 2014-06-30 | $0.14B | $0.46B | 27.29% |
| 2014-03-31 | $0.12B | $0.57B | 24.09% |
| 2013-12-31 | $0.10B | $0.52B | 22.87% |
| 2013-09-30 | $0.09B | $0.46B | 21.60% |
| 2013-06-30 | $0.08B | $0.42B | 20.33% |
| 2013-03-31 | $0.07B | $0.38B | 18.96% |
| 2012-12-31 | $0.06B | $0.41B | 16.67% |
| 2012-09-30 | $0.04B | $0.37B | 12.06% |
| 2012-06-30 | $0.02B | $0.34B | 6.15% |
| 2012-03-31 | $0.02B | $0.35B | 5.61% |
| 2011-12-31 | $0.02B | $0.40B | 5.01% |
| 2011-09-30 | $0.04B | $0.41B | 8.68% |
| 2011-06-30 | $0.06B | $0.49B | 13.28% |
| 2011-03-31 | $0.07B | $0.47B | 15.93% |
| 2010-12-31 | $0.09B | $0.49B | 19.61% |
| 2010-09-30 | $0.10B | $0.46B | 22.88% |
| 2010-06-30 | $0.10B | $0.42B | 25.45% |
| 2010-03-31 | $0.10B | $0.41B | 26.00% |
| 2009-12-31 | $0.10B | $0.39B | 27.78% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $14.370B | $8.282B |
| ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $147.378B | 27.33 |
| CVS Health (CVS) | United States | $92.778B | 11.54 |
| Elevance Health (ELV) | United States | $71.753B | 9.65 |
| Cencora (COR) | United States | $56.537B | 18.83 |
| DiDi Global (DIDIY) | China | $27.533B | 22.50 |
| Labcorp Holdings (LH) | United States | $23.101B | 18.36 |
| Natera (NTRA) | United States | $23.092B | 0.00 |
| BioMerieux (BMXMF) | France | $16.600B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.580B | 0.00 |
| Medpace Holdings (MEDP) | United States | $13.359B | 35.35 |
| CochLear (CHEOY) | Australia | $12.878B | 0.00 |
| Solventum (SOLV) | United States | $12.673B | 13.07 |
| Viatris (VTRS) | United States | $12.300B | 4.38 |
| Caris Life Sciences,�Inc (CAI) | United States | $10.796B | 0.00 |
| Revvity (RVTY) | United States | $10.459B | 18.43 |
| Avantor (AVTR) | United States | $9.183B | 13.47 |
| Charles River Laboratories (CRL) | United States | $8.037B | 15.25 |
| Sonic Healthcare (SKHHY) | Australia | $7.750B | 0.00 |
| HealthEquity (HQY) | United States | $7.725B | 33.84 |
| Bausch + Lomb (BLCO) | Canada | $5.179B | 34.83 |
| Sotera Health (SHC) | United States | $4.650B | 25.98 |
| BrightSpring Health Services (BTSG) | United States | $4.197B | 32.01 |
| Amplifon S.p.A (AMFPF) | Italy | $3.937B | 21.83 |
| GeneDx Holdings (WGS) | United States | $3.720B | 85.19 |
| Alignment Healthcare (ALHC) | United States | $3.240B | 0.00 |
| Concentras Parent (CON) | United States | $3.050B | 19.35 |
| Surgery Partners (SGRY) | United States | $2.909B | 36.60 |
| Organon (OGN) | United States | $2.449B | 2.67 |
| Premier (PINC) | United States | $2.138B | 19.77 |
| KindlyMD (NAKA) | United States | $2.046B | 0.00 |
| Progyny (PGNY) | United States | $2.035B | 43.04 |
| Ardent Health (ARDT) | United States | $1.816B | 7.01 |
| PACS (PACS) | United States | $1.774B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.511B | 25.59 |
| Pediatrix Medical (MD) | United States | $1.499B | 10.01 |
| Teladoc Health (TDOC) | United States | $1.366B | 0.00 |
| Omada Health (OMDA) | $1.364B | 0.00 | |
| Establishment Labs Holdings (ESTA) | $1.196B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.962B | 0.00 |
| Embecta (EMBC) | United States | $0.847B | 4.96 |
| AMN Healthcare Services Inc (AMN) | United States | $0.796B | 9.85 |
| CareDx (CDNA) | United States | $0.727B | 13.39 |
| Performant Healthcare (PHLT) | United States | $0.603B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.583B | 100.00 |
| Agilon Health (AGL) | United States | $0.530B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.517B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.488B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.466B | 6.99 |
| Nutex Health (NUTX) | United States | $0.465B | 7.05 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.424B | 0.00 |
| SBC Medicals (SBC) | United States | $0.424B | 9.27 |
| Enhabit (EHAB) | United States | $0.399B | 26.27 |
| So-Young (SY) | China | $0.390B | 0.00 |
| Oncology Institute (TOI) | United States | $0.318B | 0.00 |
| LifeMD (LFMD) | United States | $0.294B | 0.00 |
| Beauty Health (SKIN) | United States | $0.264B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.226B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.173B | 0.00 |
| DocGo (DCGO) | United States | $0.153B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.122B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.066B | 0.00 |
| Biodesix (BDSX) | United States | $0.063B | 0.00 |
| NeueHealth (NEUE) | United States | $0.059B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.038B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.038B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.026B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.017B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.015B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.005B | 0.00 |
| INVO Fertility (IVF) | United States | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |